SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Foghorn Therapeutics Inc. FHTX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Foghorn Therapeutics Inc. (FHTX) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ANEB, CCCC, CGEM, CSBR, CYT, EWTX 等.

FHTX 的市值为 $284.7M, 而同行平均市值为 $1.3B. FHTX 显著小于其平均同行.

同行与相似公司 — FHTX

Anebulo Pharmaceuticals, Inc.

$0.50 -0.04% $20.39M

C4 Therapeutics, Inc.

$2.76 +0.91% $228.6M

Cullinan Oncology, Inc.

$14.35 +0.70% $868.55M

Champions Oncology, Inc.

$5.73 -0.17% $79.57M

Cyteir Therapeutics, Inc.

$3.02 -2.27% $108.71M

Edgewise Therapeutics, Inc.

$33.16 -2.01% $3.56B

Monte Rosa Therapeutics, Inc.

$17.50 -0.28% $1.14B

Century Therapeutics, Inc.

$2.37 +4.41% $205.17M

Kymera Therapeutics, Inc.

$89.87 +1.51% $7.34B

Mineralys Therapeutics, Inc.

$27.32 +0.59% $1.81B

MediciNova, Inc.

$1.41 -2.08% $69.4M

Molecular Partners AG

$4.14 -1.66% $154.88M

其他人也在看

Kymera Therapeutics, Inc.

Edgewise Therapeutics, Inc.

Stoke Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Nurix Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

Cullinan Oncology, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言